This superiority in survival compared with patients without germline mutations has not been described in previous studies, and it was a somewhat unexpected result given that tumours with, e.g., SDHB mutations are known to have more aggressive phenotypes with the potential for metastases, tumour multiplicity, and recurrence [27,28]. This evidence concerns the gene SDHB and neoplasm.